Delivery Order SPE2DB22D3501-SPE2DB25FWR63
Award Date 7/31/25
Potential Completion Date 8/1/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,007.07 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, under firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $3,163.85 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract, awarded on July 24, 2025, with completion targeted for July 25, 2025, carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,398.46 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder. The contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed pricing and represents a non-competitive set-aside award. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,920.81 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is set for completion by July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $23,532.47 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a controlled-release medication commonly prescribed for attention deficit hyperactivity disorder. This firm fixed-price delivery order, issued on July 30, 2025, represents performance through July 31, 2025, and was not designated as a set-aside procurement. The contract was fulfilled from AmerisourceBergen's place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,367.29 to AmerisourceBergen Drug Corp for the supply of 100 capsules of Vyvanse 70 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. The contract, executed on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,047.13 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill...
- This is a $1,386.25 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order is for Vyvanse 20 mg capsules, which are used to treat conditions such as attention-deficit/hyperactivity disorder (ADHD). The order has an ultimate completion date of April 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,738.42 firm fixed-price delivery order is for the supply of Vyvanse 30 mg capsules, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded a $4.87K firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...